Anti-tumor effects of polyvaccine of Staphylococcus-Proteus-Escherichia-Klebsiella and polychemotherapy

Focus on Science and Technology from a Georgian Perspective

Volumn , Issue , 2011, Pages 7-13

  Gambashidze, Ketevan ^a   Khorava, Paata ^b   Bejitashvili, Nino ^a  

^a TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^b National Cancer Center   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896168550     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (20)

1. Abe H. - Antitumor effect of LPS immobilized beads. //Nippon Geka Gakkai Zasshi. 1991;92:627-35.
2. Akhmatova N., Lebedinskaia E., Kuzmenko O. et all - Effect of bacterial vaccine on anti-yumor immunity and functional activity of mononuclears suppressed by cysplatine //Sibirian Oncology Jurnal 2009. No.1 (31), p. 53-71.
3. Berezhnaia N. - The role of cells of immune system in microenvironment of the tumor. Cytokine cells - involved in inflammation // Oncology, 2009, v. 11, No. 1, p. 121-144.
4. Berezhnaia N., Chernukh V. - Immunology of cancer growth //Naukova dumka, 2005, "Kiev".
5. Coley WB. Further observations upon the treatment of malignant tumors with the toxins of erysipelas and Bacillus prodigiosus with a report of 160 cases. //John Hopkins Hospital Bulletin, 1896 ;7:175-181.
6. Coley, William B. "A Preliminary Note on the Treatment of Inoperable Sarcoma by the Toxic Product of Erysipelas." //Post-graduate, 1893, 8:278-281.
7. Gordon B., Matus R., Saatz S. et al. Protein A - Independent Tumorocidal Responses in Dogs After Extracorporeal Perfusion of Plasma Over Staphylococcus aureus. //J.N.C.I., 1983, 70, 6, 1127-1132.
8. Havas H, Axelrod R, Burns M, et al., Clinical results and immunologic effects of a mixed bacterial vaccine in cancer patients. //Medical Oncology and Tumor Pharmacotherapy, 1993;10(4):145-158.
9. Hobohm U, Stanford JL, Grange JM. Pathogen-associated molecular pattern in cancer immunotherapy. //Crit. Rev. Immunol. 2008;28(2):95-107.
10. Johnston B. Clinical effects of Coley's Toxins. 1. Controlled study. 2. A seven-year study. //Cancer Chemotherapy Reports, 1962;21:19-68.
11. Klausner J.S., Miller W.I., Brien D.O., Branda R.F. Effects of Plasma Treatment with Purified Protein A and Staphylococcus aureus Cowan 1 on Spontaneus Animal Neoplasms. //Cancer Res., 1985, 45, 1263-1268.
12. Kolmel K, et al. Treatment of advanced malignant melanoma by a pyrogenic bacterial lysate. A pilot study. //Onkologie. 1991;14:411-417.
13. Korosteliov S. - Anti-cancer vaccines //Modern oncology, 2003, v. 5, No.4, p. 12-17.
14. Murphy K., Travers P., Walport M. - Janeway's Immunobiology, 2008, Garland Science.
15. Olishevski S., Kozak V. et all. - Immunostimulating CpG-DNA: Perspectives of application in oncology //Oncology, 2006, v. 8, No. 2, p.43-44.
16. Ray P., Raychaudhuri S., Alien P. Mechanism of Regression of Mammary Adenocarcinomas in Rats following of Plasma Adsorption Over Protein A.-conteining Nonviable Staphylococcus aureus // Cancer, 1982; 42, 4970-4981.
17. Richardson M, Ramirez T, Russell N., Moye L. Coley toxins immunotherapy: a retrospective review. //Alternative Therapies in Health and Medicine, 1999 ; 5(3): 42-47.
18. Tizard Y., Veterinary immunology, 2004, Philadelphia, Pennsylvania.
19. Tsung K., Norton JA. "Lessons from Coley's Toxin". //Surgical oncology, 2006, . 15 (1): 25-28.
20. Zacharski L, Sukhatme V. Coley's toxin revisited: Immunotherapy or plasminogen activator therapy of cancer? //J. Thromb. Haemost., 2005; 3:424-27.